Corrigendum to: Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong (Diabetic Medicine, (2017), 34, 9, (1276-1283), 10.1111/dme.13416);Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong

Diabetic Medicine

Volumn 34, Issue 9, 2017, Pages 1276-1283

  Jiao, F ^a   Wong, C K H ^a   Tang, S C W ^a   Fung, C S C ^a   Tan, K C B ^a   McGhee, S ^a   Gangwani, R ^a   Lam, C L K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC COMPLICATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE COST; HEALTH CARE SURVEY; HEART DISEASE; HONG KONG; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY MEDICAL CARE; AGED; CHRONIC KIDNEY FAILURE; DIABETIC ANGIOPATHY; ECONOMICS; HEART INFARCTION; PUBLIC HEALTH;

AGED; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEALTH CARE COSTS; HONG KONG; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PUBLIC HEALTH; STROKE;

EID: 85023179698     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13953     Document Type: Erratum

References (30)

1. International Diabetes Federation. Diabetes Atlas, 7th edn. IDF, 2015.
2. Kung K, Chow KM, Hui EM-T, Leung M, Leung SY, Szeto CC et al. Prevalence of complications among Chinese diabetic patients in urban primary care clinics: a cross-sectional study. BMC Fam Pract 2014; 15: 8.
3. Liu Z, Fu C, Wang W, Xu B. Rersearch prevalence of chronic complications of type 2 diabetes mellitus in outpatients–a crosssectional hospital based survey in urban China. Health Qual Life Outcomes 2010; 8: 62.
4. Hoffmann F, Claessen H, Morbach S, Waldeyer R, Glaeske G, Icks A. Impact of diabetes on costs before and after major lower extremity amputations in Germany. J Diabetes Complications 2013; 27: 467–472.
5. Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PloS One 2011; 6: e26864.
6. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003; 26: 2300–2304.
7. Ramsey S, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH. Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 1999; 16: 285–295.
8. Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003; 20: 442–450.
9. Kim TH, Chun KH, Kim HJ, Han SJ, Kim DJ, Kwak J et al. Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean National Diabetes Program. J Kor Med Sci 2012; 27: 876–882.
10. O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ. Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie US. Diabetes Care 1998; 21: 1122–1128.
11. Alva M, Gray A, Mihaylova B, Leal J, Holman R. The impact of diabetes costs of Complications Resulting From Type 2 Diabetes from the UKPDS (UKPDS 84). Diabetic Med 2015; 32: 459–466.
12. Turner R, Holman R, Cull C, Stratton I, Matthews D, Frighi V et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.
13. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.
14. Chan B, Tsang M, Lee V, Lee K. Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. Int J Clin Pharmacol Ther. 2007; 45: 455–468.
15. Hospital Authority. Hospital Authority In-Focus. Hong Kong: 2006.
16. Janus E, Wat N, Lam K, Cockram C, Siu S, Liu L et al. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Diabet Med 2000; 17: 741–745.
17. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006; 73: 126–134.
18. Fung CS, Chin WY, Dai DS, Kwok RL, Tsui EL, Wan YF et al. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients. BMC Fam Pract 2012; 13: 116.
19. Jiao F, Fung CS, Wan YF, McGhee SM, Wong CK, Dai D et al. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study. Cardiovasc Diabetol 2015; 14: 105.
20. Wong CK, Wong WC, Wan Y, Chan AK, Chan FW, Lam CL. Patient Empowerment Programme (PEP) and Risk of Microvascular Diseases Among Patients With Type 2 Diabetes in Primary Care: A Population-Based Propensity-Matched Cohort Study. Diabetes Care 2015; 38: e116–e117.
21. Wong C, Wong W, Wan Y, Chan A, Chung K, Chan F et al. Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. Diabetes Obes Metab 2015; 17: 128–135.
22. Jiao F, Wong CKH, Gangwani R, Tan KCB, Tang SCW, Lam CLK. Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: Decrements associated with individual complication and number of complications. Health Qual Life Outcomes 2017; 15: 125.
23. HKSAR. Hospital authority ordinance (Chapter 113) Revisions to List of Charges, Hong Kong: Hospital Authority, 2013.
24. Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, Van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory-European Version: development of an instrument for international research EPSILON Study 5. Br J Psychiatry 2000; 177: s28–s33.
25. Carls GS, Gibson TB, Driver VR, Wrobel JS, Garoufalis MG, DeFrancis RR et al. The economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers. J Am Podiat Med Assoc 2011; 101: 93–115.
26. Morbach S, Furchert H, Gröblinghoff U, Hoffmeier H, Kersten K, Klauke G-T et al. Long-Term Prognosis of Diabetic Foot Patients and Their Limbs Amputation and death over the course of a decade. Diabetes Care 2012; 35: 2021–2027.
27. Apelqvist J, Larsson J, Agardh CD. Longongnts and Their Limbs Amputation and death oot ulcers. J Intern Med 1993; 233: 485–491.
28. Joyce AT, Iacoviello JM, Nag S, Sajjan S, Jilinskaia E, Throop D et al. End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care 2004; 27: 2829–2835.
29. Ho Y-W, Chau K-F, Choy B-Y, Fung K-S, Cheng Y-L, Kwan T-H et al. Hong Kong renal registry report 2012. Hong Kong J Nephrol 2013; 15: 28–43.
30. Farshchi A, Esteghamati A, Sari AA, Kebriaeezadeh A, Abdollahi M, Dorkoosh FA et al. The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. J Diabetes Metab Disord 2014; 13: 42.